睡眠無呼吸症治療機器市場は、2026年から2030年にかけて年平均成長率(CAGR)8.5%で拡大すると予測されています。世界的な肥満率の上昇により、より多くの患者が診断や持続陽圧呼吸療法(CPAP)へと向かっています。この睡眠無呼吸症治療機器市場の概観では、2025年に北米が最大の地域、アジア太平洋が最も高い成長率を示す地域であることが示されています。 この成長率は過去の実績期間を基盤としており ...
BMC Medical retrospectively reported to the U.S. Food and Drug Administration (FDA) a recall of 20,160 Luna G3 APAP devices (model LG3600) distributed in the United States due to a firmware defect, th ...
A new analysis of the FDA's MAUDE database finds that adverse event reports for oral appliances used to treat obstructive ...
A new case report from Milan describes how a 17-month-old boy who swallowed printer fluid developed severe chemical ...
The Council is supporting more than 700 resident physicians at Boston Medical Center in their efforts to secure a fair union contract. During this week’s Council meeting, the Council adopted a ...
Morning Overview on MSN
A firmware bug can shut off 20,160 recalled sleep apnea machines mid-therapy
The Food and Drug Administration has classified a firmware defect in 20,160 BMC Medical sleep apnea machines as a Class 1 recall, its most serious category, after finding the devices can display an ...
Medicare will rent a CPAP for 13 months and then hand it over free and clear, but buried inside that arrangement is a compliance test most new patients never hear about until they fail it and the ...
The Supreme Court on Tuesday issued notice on a plea filed by former Mumbai Mayor and Shiv Sena (UBT) leader Vishakha Raut challenging her disqualification as a Brihanmumbai Municipal Corporation (BMC ...
ResMed Inc. (NYSE:RMD) is well positioned to benefit from the long-term growth of the global obstructive sleep apnea (OSA) treatment market. Likewise, the company remains well positioned to benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results